Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
A. Biswas
Observed name:
A Biswas
Institution:
All India Institute of Medical Sciences
Observed institutions:
Lancashire Teaching Hospitals NHS Foundation Trust,
Royal Preston Hospital,
All India Institute of Medical Sciences
ORCID:
0000-0002-5622-7226
Observed ORCID:
0000-0002-5622-7226
OpenAlex ID:
A5087906348
Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors
2016
·
Z. A. Kapacee
, S. Susnerwala
, et al.
·
Colorectal Disease
·
22
Irinotecan+5-fluorouracil with concomitant pre-operative radiotherapy in locally advanced non-resectable rectal cancer: a phase I/II study
2008
·
S M Iles
, S W Gollins
, et al.
·
British Journal of Cancer
·
19
PDF
Impact of Adjuvant Therapy on Survival in Treatment of Central Nervous System Hemangiopericytoma
2019
·
B. Devnani
, S. Gupta
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
EP-1253: Secondary central nervous system lymphoma clinical experience from a regional cancer centre in india
2018
·
A. Biswas
, L. Kashyap
, et al.
·
Radiotherapy and Oncology
PDF
Prognostic Factors for Local Recurrence, Distant Metastases and Survival in Anal Carcinoma
2014
·
Z.A. Kapacee
, S. Susnerwala
, et al.
·
Annals of Oncology
6014 POSTER G-CSF prophylaxis and neutropenic events in NHL patients receiving standard CHOP or R-CHOP – results from a retrospective study in the UK
2007
·
R. Marcus
, H. Patel
, et al.
·
European Journal of Cancer Supplements
Show more works
View as search
Works count:
7
Citation count:
41
H-index:
2
I10-index:
2
Year
Topic
Type